Fate Therapeutics Announces Three Presentations at the 2026 ASGCT Annual Meeting Highlighting Off-the-Shelf CAR T-cell Therapy Pipeline for Cancer and Autoimmune Diseases
Go back to Fate Therapeutics Announces Three Presentations at the 2026 ASGCT Annual Meeting Highlighting Off-the-Shelf CAR T-cell Therapy Pipeline for Cancer and Autoimmune Diseases| FATE THERAPEUTICS (NASDAQ: FATE) | Delayed: 2.16 +0.01 (0.47%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.15 | 52 Week High | $4.76 | |||
| Open | $2.10 | 52 Week Low | $1.46 | |||
| Day High | $2.32 | P/E | N/A | |||
| Day Low | $2.07 | EPS | $-1.91 | |||
| Volume | 7,845,630 | |||||
